Indivior
Indivior ends Suboxone saga with $385M antitrust deal
Anika Sharma
Indivior, the manufacturer of Suboxone, has taken a significant step towards closing the chapter on years of antitrust litigation related ...
Indivior Receives FDA Approval for OPVEE (nalmefene)
SG Tylor
Indivior’s OPVEE® (nalmefene) nasal spray has received FDA approval for the emergency treatment of opioid overdose in adults and pediatric ...
